Abstract

Background:Developing simplified risk assessment model based on non-laboratory risk factors that could determine cardiovascular risk as accurately as laboratory-based one can be valuable, particularly in developing countries where there are limited resources.Objective:To develop a simplified non-laboratory cardiovascular disease risk assessment chart based on previously reported laboratory-based chart and evaluate internal and external validation, and recalibration of both risk models to assess the performance of risk scoring tools in other population.Methods:A 10-year non-laboratory-based risk prediction chart was developed for fatal and non-fatal CVD using Cox Proportional Hazard regression. Data from the Isfahan Cohort Study (ICS), a population-based study among 6504 adults aged ≥ 35 years, followed-up for at least ten years was used for the non-laboratory-based model derivation. Participants were followed up until the occurrence of CVD events. Tehran Lipid and Glucose Study (TLGS) data was used to evaluate the external validity of both non-laboratory and laboratory risk assessment models in other populations rather than one used in the model derivation.Results:The discrimination and calibration analysis of the non-laboratory model showed the following values of Harrell’s C: 0.73 (95% CI 0.71–0.74), and Nam-D’Agostino χ2:11.01 (p = 0.27), respectively. The non-laboratory model was in agreement and classified high risk and low risk patients as accurately as the laboratory one. Both non-laboratory and laboratory risk prediction models showed good discrimination in the external validation, with Harrell’s C of 0.77 (95% CI 0.75–0.78) and 0.78 (95% CI 0.76–0.79), respectively.Conclusions:Our simplified risk assessment model based on non-laboratory risk factors could determine cardiovascular risk as accurately as laboratory-based one. This approach can provide simple risk assessment tool where laboratory testing is unavailable, inconvenient, and costly.

Highlights

  • Cardiovascular disease (CVD) is the most common preventable non-communicable diseases (NCD) worldwide, with an estimated 17.8 million deaths in 2017

  • Developing simplified risk assessment model based on non-laboratory risk factors that could determine cardiovascular risk as accurately as laboratory-based one can be valuable, in developing countries where there are limited resources

  • In an attempt to simplify the Persian Atherosclerotic cardiovascular disease Risk Stratification (PARS) model that we reported previously and is a laboratory-based one [22], we aim to develop a simplified Persian Atherosclerotic cardiovascular disease Risk Stratification (SPARS) model based on non-laboratory risk factors and to assess if it can predict CVD risk as accurately as the PARS laboratory-based one

Read more

Summary

Introduction

Cardiovascular disease (CVD) is the most common preventable non-communicable diseases (NCD) worldwide, with an estimated 17.8 million deaths in 2017. Developing simplified risk assessment model based on non-laboratory risk factors that could determine cardiovascular risk as accurately as laboratory-based one can be valuable, in developing countries where there are limited resources. Objective: To develop a simplified non-laboratory cardiovascular disease risk assessment chart based on previously reported laboratory-based chart and evaluate internal and external validation, and recalibration of both risk models to assess the performance of risk scoring tools in other population. The non-laboratory model was in agreement and classified high risk and low risk patients as accurately as the laboratory one Both non-laboratory and laboratory risk prediction models showed good discrimination in the external validation, with Harrell’s C of 0.77 (95% CI 0.75–0.78) and 0.78 (95% CI 0.76–0.79), respectively. Conclusions: Our simplified risk assessment model based on non-laboratory risk factors could determine cardiovascular risk as accurately as laboratory-based one. This approach can provide simple risk assessment tool where laboratory testing is unavailable, inconvenient, and costly

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.